Notícias y destacados


Joint statement on the current epidemics of new Coronavirus (IPOPI, ESID, INGID, APSID, ARAPID, ASID, CIS, LASID, SEAPID)


ESID, together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context. It is believed that PID patients might be at higher risk for this infection or a more severe course of the disease. Thus, patients with PID need to take extra care.

See attached the full statement in PDF.